Human cord blood derived unrestricted somatic stem cells (ussc)

Details for Australian Patent Application No. 2002229533 (hide)

Owner Kourion Therapeutics AG

Inventors Wernet, Peter

Agent Davies Collison Cave

Pub. Number AU-B-2002229533

PCT Pub. Number WO02/36751

Priority 60/245,168 03.11.00 US

Filing date 3 November 2001

Wipo publication date 15 May 2002

Acceptance publication date 26 July 2007

International Classifications

C12N 5/06 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

A61K 35/12 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Materials from mammals or birds

A61K 35/14 (2006.01) Medicinal preparations containing material or reaction products thereof with undetermined constitution - Blood

A61P 41/00 (2006.01) Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

C12N 5/08 (2006.01) Undifferentiated human, animal or plant cells, e.g. cell lines -

Event Publications

30 September 2004 Change of Name(s) of Applicant(s), Section 104

  Kourion Therapeutics GmbH The name of the applicant has been changed to Kourion Therapeutics AG

26 July 2007 Application Accepted

  Published as AU-B-2002229533

29 November 2007 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002229534

2002229532-Promoter for the functional characterisation of g-protein coupled receptors in the yeast saccharomyces cerevisiae